US 10125145
5-HT3 receptor antagonists
granted A61KA61K31/19A61K31/5386
Quick answer
US patent 10125145 (5-HT3 receptor antagonists) held by Takeda Pharmaceutical Company Limited expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/19, A61K31/5386, A61P, A61P1/00